Faculty profile

Lisa Chodirker

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Lisa Chodirker

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
9 publications in the last five years, latest in 2026.
Principal investigator on 1 research grant (1 CIHR), most recently in 2020.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

129

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Latest papers

A hemoglobin >120g/L trends toward improved survival without increasing vascular events in ESA-treated MDS patients.
Blood advances · 2026
Grip strength is associated with overall survival in myelodysplastic syndrome.
Blood advances · 2026
Improvement in quality of life in MDS patients who become transfusion independent after treatment
Leukemia and Lymphoma · 2025

All 21 publications

Latest funding

Trajectories of Psychosocial and Functional Outcomes among Non-Hodgkin Lymphoma (NHL) Survivors
CIHR · 2020 · Principal investigator
$260,100

All 1 grants and awards

21 publications.

A hemoglobin >120g/L trends toward improved survival without increasing vascular events in ESA-treated MDS patients.

Skorupski C, Chodirker L, Mozessohn L, England JT, Kennedy JA, Cheung MC, Chow S, Teichman J, Goldberg N, Hershenfeld SA, Tsui H, Mamedov A, Siddiqui M, Zhang L, Buckstein RJ

Blood advances2026

DOI: 10.1182/bloodadvances.2026021068 PMID: 42747869

Grip strength is associated with overall survival in myelodysplastic syndrome.

Chornenki NLJ, Mozessohn L, Chodirker L, Chow S, Kennedy JA, England JT, Cheung MC, Geddes M, Sabloff M, Christou G, Fulcher J, Rajendra A, St Hilaire E, Finn N, Zhu NY, Leber B, Garcia-Horton A, Trottier AM, Shamy A, Leitch HA, Houston BL, Landego I, Yee KWL, Nevill TJ, Storring J, Elemary M, Habib LA, Delage R, Siddiqui M, Zhang L, Buckstein RJ

Blood advances2026

DOI: 10.1182/bloodadvances.2026021036 PMID: 42782304

Improvement in quality of life in MDS patients who become transfusion independent after treatment

Wan BA, Alibhai SMH, Chodirker L, Mozessohn L, Geddes M, Zhu N, Trottier AM, St-Hilaire E, Finn N, Leber B

Leukemia and Lymphoma20255 citations

DOI: 10.1080/10428194.2024.2422844

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE

Buckstein R, Callum J, Prica A, Bowen D, Wells RA, Leber B, Heddle N, Chodirker L, Cheung M, Mozessohn L

Transfusion20248 citations

DOI: 10.1111/trf.17721

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies

Buckstein R, Callum J, Prica A, Bowen D, Wells RA, Leber B, Heddle N, Chodirker L, Cheung M, Mozessohn L

American Journal of Hematology20247 citationsOpen Access

DOI: 10.1002/ajh.27181 PMID: W4390053864

The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry

Buckstein R, Chodirker L, Yee KWL, Geddes M, Leitch HA, Christou G, Banerji V, Leber B, Khalaf D, St-Hilaire E

Leukemia and Lymphoma202314 citations

DOI: 10.1080/10428194.2022.2156793

Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes

Mozessohn L, Li Q, Liu N, Leber B, Khalaf D, Sabloff M, Christou G, Yee K, Chodirker L, Parmentier A

JCO Oncology Practice20236 citations

DOI: 10.1200/op.22.00668

A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry.

Buckstein R, Chodirker L, Mozessohn L, Yee KWL, Geddes M, Zhu N, Shamy A, Leitch HA, Christou G, Banerji V, Brian L, Khalaf D, St-Hilaire E, Finn N, Nevill T, Keating MM, Storring J, Delage R, Parmentier A, Thambipillai A, Siddiqui M, Westcott C, Cameron C, Mamedov A, Spin P, Tang D

Leukemia & lymphoma2022

DOI: 10.1080/10428194.2022.2109154 PMID: 36095125

The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes

Brailovski E, Li Q, Liu N, Leber B, Khalaf D, Sabloff M, Christou G, Yee K, Chodirker L, Parmentier A

Annals of Hematology20224 citations

DOI: 10.1007/s00277-022-04802-1

Hypermetabolic lymphadenopathy on positron emission tomography scan following COVID-19 vaccination: A mimicker of disease progression in Hodgkin lymphoma.

Suleman A, Bilbily A, Cheung M, Chodirker L

EJHaem2021Senior author

DOI: 10.1002/jha2.268 PMID: 34518831

Something wrong or missing on this profile? Suggest a correction

Lisa Chodirker

Research

Latest papers

Latest funding

A hemoglobin >120g/L trends toward improved survival without increasing vascular events in ESA-treated MDS patients.

Grip strength is associated with overall survival in myelodysplastic syndrome.

Improvement in quality of life in MDS patients who become transfusion independent after treatment

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies

The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry

Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes

A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry.

The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes

Hypermetabolic lymphadenopathy on positron emission tomography scan following COVID-19 vaccination: A mimicker of disease progression in Hodgkin lymphoma.

Trajectories of Psychosocial and Functional Outcomes among Non-Hodgkin Lymphoma (NHL) Survivors

Frequent collaborators

Lee Mozessohn

Brian Leber

Mitchell Sabloff

Versha Banerji

Jeannie Callum

Jeannie Callum

Nicole Mittmann

Ning Liu

Nancy Heddle

Kevin Imrie

David Spaner

George Tomlinson

Gary Naglie

Robert Kerbel

Shabbir Alibhai